Streetbeat News

GRPH

Graphite Bio Inc

Employees

119

Industry

Research and Development in Biotechnology

graphite bio is a next-generation gene editing company focused on the development of first-in-class therapies for patients suffering from life-threatening genetic diseases. the company’s platform harnesses the natural cellular process of homology directed repair (hdr) and targeted dna integration to precisely repair genetic defects at their source. graphite bio is leveraging its differentiated platform to advance a portfolio of transformative genetic treatments with potential for saving and dramatically improving patients’ lives

Open

3.20

Mkt cap

185M

Volume

299K

High

3.23

P/E Ratio

-0.21

52-wk high

29.82

Low

3.05

Div yield

0.32

52-wk low

3.05

Trading for GRPH was halted at 7:50:00 p.m. ET due to pending news. The halt is a temporary measure until the news affecting the company is released.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:50 pm

In Friday's pre-market session, several healthcare stocks showed significant movement. Better Therapeutics (BTTX) led the gainers with an 85.4% increase, while SELLAS Life Sciences Gr (SLS) experienced the largest drop among the losers, decreasing by 33.5%. Other notable movers include Madrigal Pharmaceuticals (MDGL) with a 22.34% increase and Lucy Scientific Discovery (LSDI) with a 25.53% decrease. The movements were attributed to various factors including quarterly earnings reports.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 1:06 pm

Trading for GRPH was halted and then resumed at 8:55 AM ET, following an update on its status.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 12:55 pm

Trading for GRPH was halted at 7:50:00 p.m. ET due to pending news. The halt is a temporary measure until the news affecting the company is released.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 11:50 pm

Mesoblast Limited's shares surged by 13.4% after announcing FDA support for an accelerated approval pathway for rexlemestrocel-L. Other stocks also saw significant movements, with Kidpik Corp. leading the gainers with a 238% increase following a reverse stock split announcement. On the losers' side, Jeffs' Brands Ltd dropped by 45.2%. The market movements were influenced by various factors including FDA approvals, strategic plans, financial results expectations, and investment proposals.

Portfolio Pulse from Avi Kapoor

March 11, 2024 | 5:41 pm

In Monday's intraday session, several healthcare stocks experienced significant movements. Regencell Bioscience led the gainers with a 130.9% increase, while Lantern Pharma topped the losers with a 22.8% decline. The movements reflect varying market capitalizations and investor reactions to company-specific news or broader sector trends.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 5:31 pm

In Monday's pre-market session, several healthcare stocks showed significant movement. TC BioPharm, Dyadic International, and Mesoblast were among the top gainers, with shares increasing by 74.5%, 21.73%, and 19.53% respectively. On the losing end, Ainos, Nexalin Technology, and Fortrea Holdings saw their shares fall by 15.6%, 11.64%, and 10.32% respectively. These movements reflect the dynamic nature of the healthcare stock market, influenced by factors such as quarterly earnings reports.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 1:06 pm

Fangdd Network Group Ltd. (NASDAQ:DUO) shares surged 78.3% in pre-market trading after announcing its 2024 strategic plan to enter the real estate stock asset services sector. Other stocks showed significant movement in pre-market trading, with Kidpik Corp. (NASDAQ:PIK) and Auddia Inc. (NASDAQ:AUUD) among the top gainers, while Semilux International Ltd. (NASDAQ:SELX) and Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) led the losers.

Portfolio Pulse from Avi Kapoor

March 11, 2024 | 12:08 pm

In Monday's pre-market session, several stocks showed significant movement. GDS Holdings Limited (GDS) saw a sharp increase after reports of investment talks by Hillhouse Capital, Boyu Capital, and CDH Investments. Other stocks like Graphite Bio, Inc. (GRPH), Kingsoft Cloud Holdings Limited (KC), Revance Therapeutics, Inc. (RVNC), NuScale Power Corporation (SMR), Hesai Group (HSAI), MicroStrategy Incorporated (MSTR), Marathon Digital Holdings, Inc. (MARA), and Coinbase Global, Inc. (COIN) also recorded gains, with some driven by upcoming financial results and others by the strength in Bitcoin.

Portfolio Pulse from Avi Kapoor

March 11, 2024 | 9:50 am

In Monday's after-market session, several healthcare stocks showed significant movement. Exicure (XCUR) led the gainers with a 70% increase, while ThermoGenesis Holdings (THMO) led the losers with an 8% decrease. Other notable movers include Sharps Technology (STSS), NanoString Technologies (NSTG), and HeartBeam (BEAT). Market capitalizations varied, highlighting the volatility in the healthcare sector.

Portfolio Pulse from Benzinga Insights

February 05, 2024 | 9:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.